Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 33 Records) |
| Query Trace: Trisomy and TP53[original query] |
|---|
| Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia. Leukemia & lymphoma 2011 Jun 52 (6): 1055-65. Pileckyte Regina, Jurgutis Mindaugas, Valceckiene Vilma, Stoskus Mindaugas, Gineikiene Egle, Sejoniene Jurgita, Degulys Andrius, Zvirblis Tadas, Griskevicius Laimon |
| NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 2012 Mar 97 (3): 437-41. Del Giudice Ilaria, Rossi Davide, Chiaretti Sabina, Marinelli Marilisa, Tavolaro Simona, Gabrielli Sara, Laurenti Luca, Marasca Roberto, Rasi Silvia, Fangazio Marco, Guarini Anna, Gaidano Gianluca, Foà Rob |
| The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 2013 Jan 121 (3): 468-75. Oscier David G, Rose-Zerilli Matthew J J, Winkelmann Nils, Gonzalez de Castro David, Gomez Belen, Forster Jade, Parker Helen, Parker Anton, Gardiner Anne, Collins Andrew, Else Monica, Cross Nicholas C P, Catovsky Daniel, Strefford Jonathan |
| B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities. Hematological oncology 2014 Mar 32 (1): 22-30. Falisi Erika, Novella Elisabetta, Visco Carlo, Guercini Nicola, Maura Francesco, Giaretta Ilaria, Pomponi Fabrizio, Nichele Ilaria, Finotto Silvia, Montaldi Annamaria, Neri Antonino, Rodeghiero Frances |
| SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. Leukemia 2014 Jan 28 (1): 108-17. Jeromin S, Weissmann S, Haferlach C, Dicker F, Bayer K, Grossmann V, Alpermann T, Roller A, Kohlmann A, Haferlach T, Kern W, Schnittger |
| Recurrent mutations refine prognosis in chronic lymphocytic leukemia. Leukemia 2015 Feb 29 (2): 329-36. Baliakas P, Hadzidimitriou A, Sutton L-A, Rossi D, Minga E, Villamor N, Larrayoz M, Kminkova J, Agathangelidis A, Davis Z, Tausch E, Stalika E, Kantorova B, Mansouri L, Scarfò L, Cortese D, Navrkalova V, Rose-Zerilli M J J, Smedby K E, Juliusson G, Anagnostopoulos A, Makris A M, Navarro A, Delgado J, Oscier D, Belessi C, Stilgenbauer S, Ghia P, Pospisilova S, Gaidano G, Campo E, Strefford J C, Stamatopoulos K, Rosenquist R, |
| NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment. Leukemia & lymphoma 2014 Dec 55 (12): 2785-92. Chiaretti Sabina, Marinelli Marilisa, Del Giudice Ilaria, Bonina Silvia, Piciocchi Alfonso, Messina Monica, Vignetti Marco, Rossi Davide, Di Maio Valeria, Mauro Francesca Romana, Guarini Anna, Gaidano Gianluca, Foà Rob |
| Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia. Hematological oncology 2016 Sep . Le Bris Yannick, Struski Stéphanie, Guièze Romain, Rouvellat Caroline, Prade Naïs, Troussard Xavier, Tournilhac Olivier, Béné Marie C, Delabesse Eric, Ysebaert Lo |
| A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2016 Dec 1-3. Salemi Michele, Barone Concetta, Salluzzo Maria Grazia, Giambirtone Mariaconcetta, Scillato Francesco, Galati Rando Rosanna, Romano Carmelo, Morale Maria Concetta, Ridolfo Federico, Romano Corra |
| The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians. Leukemia research 2017 9 61 96-103. Kim Seon Young, Kim Kwantae, Hwang Byungjin, Im Kyongok, Park Si Nae, Kim Jung-Ah, Hwang Sang Mee, Bang Duhee, Lee Dong So |
| The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. Hematology. American Society of Hematology. Education Program 2017 12 2017 (1): 329-337. Gaidano Gianluca, Rossi Davi |
| Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia. Haematologica 2018 9 104 (2): 360-369. Baliakas Panagiotis, Moysiadis Theodoros, Hadzidimitriou Anastasia, Xochelli Aliki, Jeromin Sabine, Agathangelidis Andreas, Mattsson Mattias, Sutton Lesley-Ann, Minga Eva, Scarfò Lydia, Rossi Davide, Davis Zadie, Villamor Neus, Parker Helen, Kotaskova Jana, Stalika Evangelia, Plevova Karla, Mansouri Larry, Cortese Diego, Navarro Alba, Delgado Julio, Larrayoz Marta, Young Emma, Anagnostopoulos Achilles, Smedby Karin E, Juliusson Gunnar, Sheehy Oonagh, Catherwood Mark, Strefford Jonathan C, Stavroyianni Niki, Belessi Chrysoula, Pospisilova Sarka, Oscier David, Gaidano Gianluca, Campo Elias, Haferlach Claudia, Ghia Paolo, Rosenquist Richard, Stamatopoulos Kostas, |
| Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group. Genes, chromosomes & cancer 2018 Sep . Roos-Weil Damien, Nguyen-Khac Florence, Chevret Sylvie, Touzeau Cyrille, Roux Clémence, Lejeune Julie, Cosson Adrien, Mathis Stéphanie, Feugier Pierre, Leprêtre Stéphane, Béné Marie-Christine, Baron Marine, Raynaud Sophie, Struski Stéphanie, Eclache Virginie, Sutton Laurent, Lesty Claude, Merle-Béral Hélène, Cymbalista Florence, Ysebaert Loïc, Davi Frédéric, Leblond Véronique, |
| Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma. Human pathology 2018 11 85 65-71. Schwartz Christopher J, Dolgalev Igor, Yoon Esther, Osman Iman, Heguy Adriana, Vega-Saenz de Miera Eleazar C, Nimeh Diana, Jour George, Darvishian Farb |
| Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53. Blood 2019 9 134 (21): 1821-1831. Chapiro Elise, Pramil Elodie, Diop M'boyba, Roos-Weil Damien, Dillard Clémentine, Gabillaud Clémentine, Maloum Karim, Settegrana Catherine, Baseggio Lucile, Lesesve Jean-François, Yon Mélanie, Jondreville Ludovic, Lesty Claude, Davi Frédéric, Le Garff-Tavernier Magali, Droin Nathalie, Dessen Philippe, Algrin Caroline, Leblond Véronique, Gabarre Jean, Bouzy Simon, Eclache Virginie, Gaillard Baptiste, Callet-Bauchu Evelyne, Muller Marc, Lefebvre Christine, Nadal Nathalie, Ittel Antoine, Struski Stéphanie, Collonge-Rame Marie-Agnès, Quilichini Benoit, Fert-Ferrer Sandra, Auger Nathalie, Radford-Weiss Isabelle, Wagner Lena, Scheinost Sebastian, Zenz Thorsten, Susin Santos A, Bernard Olivier A, Nguyen-Khac Florence, , |
| Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia. British journal of haematology 2019 6 187 (1): 82-92. Huang Ying-Jung, Kuo Ming-Chung, Chang Hung, Wang Po-Nan, Wu Jin-Hou, Huang Yen-Min, Ma Ming-Chun, Tang Tzung-Chih, Kuo Ching-Yuan, Shih Lee-Yu |
| Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience. Leukemia research 2019 Apr 81 75-81. Spunarova Michaela, Tom Nikola, Pavlova Sarka, Mraz Marek, Brychtova Yvona, Doubek Michael, Panovska Anna, Skuhrova Francova Hana, Brzobohata Anna, Pospisilova Sarka, Mayer Jiri, Trbusek Mart |
| DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains. Experimental hematology 2019 2 72 9-13. Hernández-Sánchez María, Rodríguez-Vicente Ana Eugenia, González-Gascón Y Marín Isabel, Quijada-Álamo Miguel, Hernández-Sánchez Jesús María, Martín-Izquierdo Marta, Hernández-Rivas José Ángel, Benito Rocío, Hernández-Rivas Jesús Mar |
| Genomic alterations in chronic lymphocytic leukemia and their correlation with clinico-hematological parameters and disease progression. Blood research 2020 8 55 (3): 131-138. Srinivasan Vishrut K, Naseem Shano, Varma Neelam, Lad Deepesh P, Malhotra Pank |
| A rare case of acute promyelocytic leukemia with ider(17)(q10)t(15;17)(q22;q21) and favorable outcome. Molecular cytogenetics 2020 4 13 13. Liu Yongming, Xu Junqing, Chu Lina, Yu Limei, Zhang Yanhong, Ma Li, Wang Weihua, Zhang Yangyang, Xu Yimin, Liu Rimi |
| Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact. American journal of hematology 2021 8 96 (12): 1569-1579. Krzisch Daphné, Guedes Nayara, Boccon-Gibod Clémentine, Baron Marine, Bravetti Clotilde, Davi Frédéric, Armand Marine, Smagghe Luce, Caron Jonathan, Bernard Olivier A, Susin Santos, Chapiro Elise, Leblond Véronique, Nguyen-Khac Florence, Roos-Weil Damien, |
| Molecular Pathology of Gliomas. Surgical pathology clinics 2021 8 14 (3): 379-386. Galbraith Kristyn, Snuderl Mati |
| Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Bone marrow transplantation 2021 Mar . Daher-Reyes Georgina, Kim TaeHyung, Novitzky-Basso Igor, Kim Kyuoung Ha, Smith Adam, Stockley Tracy, Capochichi Jose-Mario, Al-Shaibani Zeyad, Pasic Ivan, Law Arjun, Lam Wilson, Michelis Fotios V, Gerbitz Armin, Viswabandya Auro, Lipton Jeffrey, Kumar Rajat, Mattsson Jonas, Schimmer Aaron, McNamara Caroline, Murphy Tracy, Maze Dawn, Gupta Vikas, Sibai Hassan, Chan Steven, Yee Karen, Minden Mark, Zhang Zhaolei, Schuh Andre, Kim Dennis D |
| Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. Leukemia research 2022 4 116 106827. Jelloul Fatima Zahra, Yang Richard, Garces Sofia, Kanagal-Shamanna Rashmi, Ok Chi Y, Loghavi Sanam, Routbort Mark J, Zuo Zhuang, Yin C Cameron, Floyd Kristen, Bassett Roland L, Wierda William, Jain Nitin, Thompson Philip, Luthra Rajyalakshmi, Medeiros L Jeffrey, Patel Keyur |
| High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL. HemaSphere 2023 9 7 (10): e951. Paul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, Wouter Doff, Julie M N Dubois, Melissa Rijken, Jorn L J C Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten J Gussinklo, Peter J M Valk, Laura M Faber, Peter E Westerweel, Arnon P Kater, Mark-David Levin, Anton W Langer |
| Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia. Haematologica 2023 5 . Almut Lütge, Junyan Lu, Jennifer Hüllein, Tatjana Walther, Leopold Sellner, Bian Wu, Richard Rosenquist, Christopher C Oakes, Sascha Dietrich, Wolfgang Huber, Thorsten Ze |
| MYD88-Mutated Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma as a Distinctive Molecular Subgroup Is Associated with Atypical Immunophenotypes in Chinese Patients. Journal of clinical medicine 2023 4 12 (7): . Mu Yafei, Fan Xijie, Chen Tao, Meng Yuhuan, Lin Junwei, Yuan Jiecheng, Yu Shihui, Chen Yuxin, Liu Lingli |
| Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
| Molecular Pathology of Gliomas. Clinics in laboratory medicine 2024 5 44 (2): 149-159. Kristyn Galbraith, Matija Snude |
- Page last reviewed:Feb 1, 2024
- Content source: